Kenichi Nishioji

Side effects of high-dose interferon therapy for chronic hepatitis C

T Okanoue, Shinichi Sakamoto, Yoshito Itoh et al. · Journal of Hepatology · 1996 · 463 citations

Hepatology, Hepatitis C, Viral Hepatitis +6

Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients

Takeshi Okanoue, Yoshito Itoh, Masahito Minami et al. · Journal of Hepatology · 1999 · 238 citations

Immunology, Pathology, Chronic Hepatitis C +16

Expression of IFN-inducible protein-10 in chronic hepatitis

Shosaku Narumi, Yoshiharu Tominaga, Masahiro Tamaru et al. · The Journal of Immunology · 1997 · 167 citations

Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012

Kenichi Nishioji, Yoshio Sumida, Mai Kamaguchi et al. · Journal of Gastroenterology · 2014 · 159 citations

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +12

Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes

Kenichi Nishioji, Takeshi Okanoue, Yoshito Itoh et al. · Clinical & Experimental Immunology · 2001 · 139 citations · Full text